Filter
788
Filtered Results: 788
Text search:
Foundation
for
Innovative
and
New
Diagnostics
Featured
Recommendations
72
New Publications
210
Language
Document type
No document type
435
Studies & Reports
148
Guidelines
84
Strategic & Response Plan
60
Manuals
40
Fact sheets
10
Situation Updates
6
Training Material
4
Infographics
1
Countries / Regions
Global
48
India
25
Kenya
22
Africa
20
Ethiopia
16
Uganda
16
Western and Central Europe
16
Latin America and the Carribbean
14
Nigeria
13
Myanmar / Burma
13
Tanzania
12
South Africa
12
Asia
12
Malawi
11
Ghana
10
Rwanda
10
East and Southern Africa
10
Eastern Europe
10
Liberia
9
Sierra Leone
8
West and Central Africa
8
South–East Asia Region
8
Nepal
7
Zambia
7
Bangladesh
7
Ukraine
7
Mozambique
6
Philippines
5
Middle East and North Africa
5
Guinea
4
Senegal
4
Pakistan
4
South Sudan
4
Germany
4
Georgia
4
Congo, Democratic Republic of
3
Zimbabwe
3
Haiti
3
Afghanistan
3
Syria
3
Namibia
3
Lesotho
3
Western Pacific Region
3
Russia
3
Cameroon
2
Cambodia
2
Indonesia
2
Peru
2
Botswana
2
Angola
2
Sri Lanka
2
Burkina Faso
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Somalia
1
Iraq
1
Chad
1
Thailand
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Argentina
1
Eswatini/ Swaziland
1
Brazil
1
North Macedonia
1
Colombia
1
Ecuador
1
Madagascar
1
Yemen
1
Eastern Europe and Central Asia
1
Bhutan
1
Armenia
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Qatar
1
Estonia
1
Lithuania
1
Moldova
1
Belgium
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
237
Clinical Guidelines
77
Public Health
61
Pharmacy & Technologies
28
Key Resources
21
Women & Child Health
19
Capacity Building
5
Toolboxes
TB
107
HIV
99
COVID-19
60
Mental Health
42
NTDs
37
AMR
32
Planetary Health
26
Health Financing Toolbox
25
Global Health Education
20
Rapid Response
19
Caregiver
19
Disability
12
Pharmacy
12
NCDs
12
Ebola
10
Conflict
10
Polio
7
Natural Hazards
4
Zika
3
Cholera
2
Refugee
2
South Sudan
1
Health Financing
1
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populatio...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, ... vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course of this pandemic are within reach. But to deliver the full impact of the ACT-Accelerator – and ultimately an exit to this global crisis – these tools need to be available everywhere. On behalf of the ACT-Accelerator Pillar lead agencies – CEPI, Gavi, the Global Fund, FIND, Unitaid, Wellcome Trust, the World Bank, and the World Health Organization, as well as the Bill & Melinda Gates Foundation – I am pleased to share this document setting out the near-term priorities, deliverables and financing requirements of the ACT-Accelerator Pillars and Health Systems Connector. Urgent action to address these financing requirements will boost the impact of the ACTAccelerator achievements to date, fast-track the development and deployment of additional game-changing tools, and mitigate the risk of a widening gap in access to COVID-19 tools between low- and high-income countries. Delivering on this promise requires strong political leadership, financial investment, and incountry capacity building. COVID-19 cannot be beaten by any one country acting alone. We must ACT now, and ACT together to end the COVID-19 crisis.
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new<...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- ...
This document provides brief information answering common questions regarding COVID-19 diagnostic tests and how to prioritize them to the patients most in need.
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a ... landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions.
We conducted literature reviews and interviews with key stakeholders to identify use cases for HAT diagnostics, understand current practices, and analyze progress toward more robust diagnostics across
different biomarkers.
"Some of the problems with our current drug policies stem from the fact that these policies have been largely bifurcated between two different and often contradictory approaches. One treats drug use as a crime that cannot be tolerated ... should be punished; the other views addiction as a chronic relapsing health or behavioral condition requiring ongoing treatment and support. Neither of these views is all encompassing—it should be recognized that there are patterns of drug use that do not result in significant harm or health problems and therefore require no intervention. The public health approach presented here takes the view that our focus should be on the harm caused by drug use and the harm caused by our policy responses to it. We have focused specifically on illicit drugs, not because they are by themselves more harmful (in fact, tobacco causes more morbidity and mortality than any illicit drug), but because it has become increasingly clear that our current policies to manage illicit drugs are failing."
As the Group of Eight (G8) world leaders meet in Saint Petersburg, Russia for this year’s G8 Summit, it is important to take stock of international efforts to finance the response to the global HIV/AIDS epidemic. Financing a sufficient ... sustained response to the epidemic has emerged as one of the world’s greatest challenges, and one that will be with us for the foreseeable future. Often, those countries most affected are also least able to respond, increasing their vulnerability to HIV/AIDS and in turn further complicating their ability to address the epidemic, as is the case for many nations in sub-Saharan Africa. In addition, concerns have been raised about “second wave” nations, particularly China, India, and Russia, which stand on the brink of generalized epidemics if more is not done now
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes...
Organizing and Delivering High Quality Care for Chronic Noncommunicable Diseases in the Americas
Second Edition
AIDS Medicines and diagnostics services
July 2015
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishm...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their surviva...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic...
This WHO information note provides an updated list of recommended criteria for selecting RDTs for malaria, and highlights the performance of RDTs e...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. ...
This European compendium was produced to provide operational examples of the new nursing and midwifery roles and ... service delivery models currently being employed across the Region. The case studies directly relate to the priority areas in Health 2020 and exemplify the types of activities needed to fully implement the objectives within the Strategic Directions framework.
The report summarizes key global health expenditure patterns and trends, and illustrates the potential of the new database to inform thinking about...
